https://vitalspanwire.com/news/pepopt-interpretable-modeling-peptide-drug-designVitalspan Wireen2026-10-14T21:01:58.915ZPepOpt study introduces interpretable modeling for peptide drug designhttps://vitalspanwire.com/news/tovinontrine-heart-failure-biomarker-cycle-trialsVitalspan Wireen2026-10-14T16:02:17.433ZTovinontrine misses heart-failure biomarker endpoint in preserved-ejection-fraction trialhttps://vitalspanwire.com/news/exercise-menopause-review-mood-quality-of-lifeVitalspan Wireen2026-10-14T11:02:10.446ZExercise review finds potential mood benefits during menopause, with evidence limitationshttps://vitalspanwire.com/news/eb613-osteoporosis-subgroup-bone-density-asbmrVitalspan Wireen2026-10-13T21:01:35.485ZEB613 update reports larger bone-density gains in small osteoporosis subgroupshttps://vitalspanwire.com/news/cancer-cachexia-weight-loss-episodes-prediction-studyVitalspan Wireen2026-10-13T16:01:43.663ZCancer study maps weight-loss episodes and tests prediction across hospital cohortshttps://vitalspanwire.com/news/menopause-study-abrupt-laboratory-changesVitalspan Wireen2026-10-13T11:01:30.763ZMenopause study maps abrupt laboratory changes, with interpretation disputed